| |
| |
|
| Insider
Information: |
Vazzano Joseph Walter |
| Relationship: |
Chief Financial Officer |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
399,625 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$44,809 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
399,625 |
|
|
| Total
Value |
$44,809 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Avenue Therapeutics, Inc. |
ATXI |
Chief Financial Officer |
2021-12-17 |
165,757 |
|
0 |
Premium* |
|
|
Abeona Therapeutics Inc |
ABEO |
Chief Financial Officer |
2024-04-25 |
233,868 |
2022-03-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ABEO |
Abeona Therapeutics Inc |
Chief Financial Officer |
• – – |
2024-04-25 |
4 |
B |
$3.14 |
$17,609 |
D/D |
5,608 |
233,868 |
2.74 |
- |
|
| ABEO |
Abeona Therapeutics Inc |
Chief Financial Officer |
• – – |
2024-03-15 |
4 |
D |
$8.14 |
$5,722 |
D/D |
(703) |
228,260 |
0 |
- |
|
| ABEO |
Abeona Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-09-29 |
4 |
D |
$3.93 |
$24,484 |
D/D |
(6,230) |
228,963 |
0 |
- |
|
| ABEO |
Abeona Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-09-19 |
4 |
B |
$3.70 |
$11,458 |
D/D |
3,000 |
238,179 |
2.74 |
- |
|
| ABEO |
Abeona Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-07-24 |
4 |
D |
$3.73 |
$4,428 |
D/D |
(1,187) |
235,179 |
0 |
- |
|
| ABEO |
Abeona Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
141,908 |
236,366 |
0 |
- |
|
| ABEO |
Abeona Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-03-15 |
4 |
D |
$2.60 |
$2,059 |
D/D |
(792) |
94,458 |
0 |
- |
|
| ABEO |
Abeona Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-11-18 |
4 |
B |
$4.00 |
$10,000 |
D/D |
2,500 |
95,250 |
2.74 |
- |
|
| ABEO |
Abeona Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-09-28 |
4 |
A |
$0.00 |
$0 |
D/D |
72,750 |
92,750 |
0 |
- |
|
| ABEO |
Abeona Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
20,000 |
0 |
- |
|
| ABEO |
Abeona Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
200,000 |
0 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
100,505 |
165,757 |
0 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-09-15 |
4 |
S |
$1.62 |
$11,599 |
D/D |
(7,160) |
65,252 |
0 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-08-20 |
4 |
S |
$12.13 |
$46,579 |
D/D |
(3,840) |
57,412 |
0 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-03-10 |
4 |
B |
$7.94 |
$14,999 |
D/D |
1,889 |
61,252 |
2.74 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-03-09 |
4 |
B |
$7.97 |
$11,983 |
D/D |
1,500 |
59,363 |
2.74 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-02-25 |
4 |
B |
$9.09 |
$10,908 |
D/D |
1,200 |
57,863 |
2.74 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2019-08-09 |
4 |
S |
$5.56 |
$13,205 |
D/D |
(2,375) |
56,663 |
0 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2019-08-08 |
4 |
S |
$5.62 |
$12,999 |
D/D |
(2,313) |
59,038 |
0 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
VP Finance & Corp. Controller |
• – – |
2018-08-07 |
4 |
GA |
$0.00 |
$0 |
D/D |
30,000 |
61,351 |
0 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
VP Finance & Corp. Controller |
• – – |
2018-06-28 |
4 |
A |
$3.66 |
$4,945 |
D/D |
1,351 |
31,351 |
0 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
VP Finance & Corp. ControllerO |
• – – |
2017-08-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
30,000 |
|
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
